Article Details

AveXis name recognition and Zolgensma legacy hook Lilly in Jaguar's $139M series B

Retrieved on: 2021-04-13 12:22:30

Tags for this article:

Click the tags to see associated articles and topics

AveXis name recognition and Zolgensma legacy hook Lilly in Jaguar's $139M series B. View article details on hiswai:

Excerpt

Other investors in the series B included Goldman Sachs, Arch Venture Partners and Nolan Capital. Jaguar CEO Joe Nolan said Lilly doesn't typically ...

Article found on: www.fiercebiotech.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up